Showing results (21-30 of 119) with videos related to
Sort By:
Pageof 12
International Review of Neurobiology|June 22, 2020
Strategies to minimize placebo effects in research investigationsFilipe B Rodrigues, Joaquim J FerreiraBrain Communications|November 16, 2022
Longitudinal evaluation of proton magnetic resonance spectroscopy metabolites as biomarkers in Huntington's diseaseAlexander J Lowe, Filipe B Rodrigues, Marzena Arridge, et al.Journal of Neurochemistry|April 2, 2021
Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's diseaseFilipe B Rodrigues, Lauren M Byrne, Alexander J Lowe, et al.The Lancet. Neurology|June 12, 2017
Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysisLauren M Byrne, Filipe B Rodrigues, Kaj Blennow, et al.Journal of Huntington'S Disease|April 1, 2016
Cerebrospinal Fluid Biomarkers for Huntington's DiseaseLauren M Byrne, Edward J WildThe Lancet. Neurology|September 19, 2017
Therapies targeting DNA and RNA in Huntington's diseaseEdward J Wild, Sarah J TabriziMovement Disorders : Official Journal of the Movement Disorder Society|October 31, 2009
Serial volumetric MRI in Parkinsonian disordersEdward J Wild, Nick C FoxTrends in Molecular Medicine|October 25, 2011
HDBuzz: empowering patients through accessible educationEdward J Wild, Jeffrey B CarrollCurrent Opinion in Neurology|November 10, 2007
Huntington's disease phenocopy syndromesEdward J Wild, Sarah J TabriziMovement Disorders : Official Journal of the Movement Disorder Society|August 27, 2014
Targets for future clinical trials in Huntington's disease: what's in the pipeline?Edward J Wild, Sarah J TabriziPageof 12